Wenge Lu
- Oncology top 5%
- Cancer-related Molecular Pathways 9
- Biotechnology top 5%
- Cancer Research and Treatments 7
-
- Cancer, Hypoxia, and Metabolism 3
- Cell Biology top 10%
-
- Ubiquitin and proteasome pathways 3
- RNA modifications and cancer 2
-
- Immune Response and Inflammation 4
-
- Infant Nutrition and Health 4
-
- Neonatal Respiratory Health Research 3
- Co-authors
- Jiandong ChenYanhua PengLihong ChenШломо МелмедChanggong LiRun YuDarlene A CalhounRobert D. Christensen
- Cited by
- OncologyBiotechnologyCancer Research
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Wenge Lu
18 papers receiving 981 citations
Peers
Comparison fields: 5 of 87
- Oncology 487
- Biotechnology 107
- Cancer Research 141
- Cell Biology 139
- Molecular Biology 564
Countries citing papers authored by Wenge Lu
This map shows the geographic impact of Wenge Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenge Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenge Lu more than expected).
Fields of papers citing papers by Wenge Lu
This network shows the impact of papers produced by Wenge Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenge Lu. The network helps show where Wenge Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenge Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 29 | |
| 2 | 2005 | 14 | |
| 3 | 2005 | 29 | |
| 4 | 2004 | 59 | |
| 5 | 2004 | 36 | |
| 6 | 2004 | 7 | |
| 7 | 2003 | 26 | |
| 8 | 2003 | 108 | |
| 9 | 2002 | 63 | |
| 10 | Expression of p14ARF overcomes tumor resistance to p53. | 2002 | 32 |
| 11 | 2001 | 55 | |
| 12 | 2001 | 153 | |
| 13 | 2001 | 94 | |
| 14 | 2000 | 13 | |
| 15 | 2000 | 72 | |
| 16 | 2000 | 100 | |
| 17 | 1999 | 59 | |
| 18 | 1999 | 65 |
About Wenge Lu
Wenge Lu is a scholar working on Biotechnology, Oncology, Nutrition and Dietetics, Cancer Research and Immunology, having authored 18 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Cancer Research and Treatments (7 papers), Immune Response and Inflammation (4 papers), Infant Nutrition and Health (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Ubiquitin and proteasome pathways (3 papers), Neonatal Respiratory Health Research (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (487 citations), Biotechnology (107 citations), Cancer Research (141 citations), Cell Biology (139 citations) and Molecular Biology (564 citations). Wenge Lu has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jiandong Chen, Yanhua Peng, Lihong Chen, Шломо Мелмед, Changgong Li, Run Yu, Darlene A Calhoun, Robert D. Christensen, Akhil Maheshwari and Radhika Pochampally. Their work appears in journals such as Journal of Biological Chemistry, Pediatric Research, Cytokine, Oncogene and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.